New insights into NAFLD based on preclinical MRI studies

被引:1
|
作者
Bamburowicz-Klimkowska, Magdalena [1 ]
Ruzycka-Ayoush, Monika [1 ]
Cieszanowski, Andrzej [2 ,3 ,4 ]
Szeszkowski, Wojciech [4 ]
Bialek, Malgorzata [5 ]
Malkowska, Anna [1 ]
Grudzinski, Ireneusz P. [1 ]
机构
[1] Med Univ Warsaw, Dept Appl Toxicol, Banacha 1, PL-02097 Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiol 1, Roentgena 5, PL-02781 Warsaw, Poland
[3] Inst Oncol, Roentgena 5, PL-02781 Warsaw, Poland
[4] Med Univ Warsaw, Dept Clin Radiol, Banacha 1a, PL-02097 Warsaw, Poland
[5] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Inst 3, PL-05110 Jablonna, Poland
关键词
Fatty liver; Whole-body fat distribution; Magnetic resonance imaging; Rats; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; OBESITY; EPIDEMIC; VOLUME;
D O I
10.1016/j.chemphyslip.2022.105192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ABSTR A C T Background: Non-alcoholic fatty liver disease (NAFLD) is considered to be the leading cause of liver pathologies worldwide. Accurate diagnosis and staging of NAFLD is of utmost prognostic importance. Herein, we propose the application of multiparametric MRI in whole-body fat imaging that may serve in obesity and NAFLD diagnosis as we established based on an experimental preclinical model of high-calorie diet-induced NAFLD rats.Methods and results: Sprague Dawley male rats randomly divided into control and high-fat diet (HFD) groups to develop NAFLD were used in the experiments. After 12 weeks of the feeding the animals were subjected to MRI modalities based on the Dixon mode and DWI following T2-weighted imaging. Moreover, serum TAG, liver histopathological examination and liver fatty acids analysis (GC-MS) were also performed.The qualitative analysis of DWI images revelated the decrease of signals in the liver of rats subjected to HFD. The statistical analysis of signals from the water-and fat-separated voxels on Dixon images also showed the increase of the fat tissue along with the decrease of water molecules in the liver parenchyma of obese animals. The quantitative analysis of Dixon images allowed to estimate the statistically significant changes of whole-body fat profiles in both normal and obese rats. Histological analysis of the liver tissues, serum TAG and fatty acids profile in the livers confirmed the changes in the fat profile as demonstrated in MRI studies.Conclusions: The MRI-based modalities such as DWI and Dixon method provide both qualitative and quantitative data on the whole-body fat distribution and adipose tissues in the liver parenchyma of obese rats. The results show that MRI is a promising and reliable method and has potential to be used as a non-invasive translational biomarker in NAFLD.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Preclinical animal acute toxicity studies of new developed MRI contrast agent based on gadolinium
    Nam, I. F.
    Zhuk, V. V.
    INTERNATIONAL SCIENTIFIC CONFERENCE ON RADIATION-THERMAL EFFECTS AND PROCESSES IN INORGANIC MATERIALS, 2015, 81
  • [2] Preclinical MRI: Studies of the irradiated brain
    Garbow, Joel R.
    Tsien, Christina, I
    Beeman, Scott C.
    JOURNAL OF MAGNETIC RESONANCE, 2018, 292 : 73 - 81
  • [3] Editorial: New Insights Into Understanding and Managing NAFLD
    Escribano, Oscar
    Frances, Daniel E.
    Otero, Yolanda F.
    Egea, Javier
    Gonzalez-Rodriguez, Agueda
    FRONTIERS IN MEDICINE, 2021, 8
  • [4] New insights into NAFLD and subclinical coronary atherosclerosis
    VanWagner, Lisa B.
    JOURNAL OF HEPATOLOGY, 2018, 68 (05) : 890 - 892
  • [5] Targeting the MGBA with -biotics in epilepsy: New insights from preclinical and clinical studies
    Riva, Antonella
    Pozzati, Elisa
    Grasso, Mattia
    De Caro, Carmen
    Russo, Emilio
    Verrotti, Alberto
    Striano, Pasquale
    NEUROBIOLOGY OF DISEASE, 2022, 170
  • [6] New insights into preclinical Alzheimer disease
    Katie Kingwell
    Nature Reviews Neurology, 2013, 9 (1) : 4 - 4
  • [7] From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
    Cynthia L. Hsu
    Rohit Loomba
    Nature Metabolism, 2024, 6 : 600 - 602
  • [8] From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
    Hsu, Cynthia L.
    Loomba, Rohit
    NATURE METABOLISM, 2024, 6 (04) : 600 - 602
  • [9] THE SEROTONIN RECEPTOR AGONIST PSILOCYBIN AS A NOVEL THERAPEUTIC APPROACH FOR NAFLD: PRECLINICAL STUDIES
    De Martin, Sara
    Gabbia, Daniela
    Colognesi, Martina
    Zanotto, Ilaria
    Sayaf, Katia
    Comai, Stefano
    Mattarei, Andrea
    Banzato, Marco
    Folli, Franco
    Centofanti, Lucia
    Traversa, Sergio
    Pappagallo, Marco
    Manfredi, Paolo L.
    HEPATOLOGY, 2023, 78 : S1222 - S1223
  • [10] VEGF inhibition: insights from preclinical and clinical studies
    Crawford, Yongping
    Ferrara, Napoleone
    CELL AND TISSUE RESEARCH, 2009, 335 (01) : 261 - 269